Severe preeclampsia

Current Women's Health Reviews

Volumn 7, Issue 2, 2011, Pages 112-124

  Pridjian, Gabriella ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eclampsia; Intensive care; Preeclampsia

Indexed keywords

AMOBARBITAL; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; FUROSEMIDE; GLUCOCORTICOID; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; LABETALOL; LIVER ENZYME; MAGNESIUM SULFATE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN; PLACENTAL GROWTH FACTOR; VALPROIC ACID; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTERY CATHETERIZATION; ARTERY CONSTRICTION; ARTERY SPASM; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD PRESSURE VARIABILITY; BLOOD VOLUME; CARDIOMEGALY; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL FEATURE; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; CRYSTALLOID; DELIVERY; DIAGNOSTIC TEST; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE TITRATION; ECLAMPSIA; FEMALE; FETUS LUNG MATURITY; FETUS MORTALITY; GESTATIONAL AGE; GLOMERULUS ENDOTHELIOSIS; HEART ARRHYTHMIA; HEART RATE; HEART STROKE VOLUME; HELLP SYNDROME; HEMODYNAMIC MONITORING; HEMOLYTIC ANEMIA; HUMAN; HYPERTENSION ENCEPHALOPATHY; HYPOTENSION; INTENSIVE CARE; INTRAPARTUM CARE; KIDNEY DISEASE; KIDNEY FAILURE; LIVER RUPTURE; LOADING DRUG DOSE; LUNG EDEMA; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; NEUROMUSCULAR BLOCKING; PLACENTA PERFUSION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; POSTOPERATIVE HEMORRHAGE; PREECLAMPSIA; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RISK FACTOR; SEIZURE; SIDE EFFECT; SOLUTIO PLACENTAE; STROKE; THROMBOCYTE COUNT; VASCULAR RESISTANCE; VISUAL IMPAIRMENT; WOUND HEALING IMPAIRMENT;

EID: 79955722708     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340411795445785     Document Type: Article

References (124)

1. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97: 533-48.
2. Cunningham FG, Lindheimer, MD: Hypertension in pregnancy. N Engl J Med 1992; 326: 927-31.
3. Saftlas AF, Olson DR, Franks AL, et al. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990; 163: 460-5.
4. Lindheimer MD. Hypertension in pregnancy. Hypertension 1993; 22: 127-37.
5. Burrows RF, Burrows EA. The feasibility of a control population for a randomized controlled trial of seizure prophylaxis in the hypertensive disorder of pregnancy. Am J Obstet Gynecol 1995; 173: 929-35.
6. Hypertensive disorders in pregnancy. In: Cunningham FG, MacDonald PC, Gant WF, Eds. William Obstetrics, 20th ed. Stamford: Appleton & Lange, 1997; pp. 693-744.
7. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
8. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 99: 159-67.
9. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens 2008; 2(6): 484-94.
10. The collaborative perinatal study of the National Institute of Neurological Diseases and Stroke. The women and their pregnancies, Washington DC: US Department of Health, Education, and Welfare, 1972; DHEW publication no. (NIH) 73-379.
11. Chesley LC. History and epidemiology of preeclampsia-eclampsia. Clin Obstet Gynecol 1984; 27: 801-20.
12. Rey E, Courturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994; 171: 410-6.
13. Mabie WC, Pernoll ML, Biswas MK. Chronic hypertension in pregnancy. Obstet Gynecol 1986; 67: 197-205.
14. Lindheimer MD, Davison JM, Katz AI. The kidney and hypertension in pregnancy: twenty exciting years. Seminars in Nephrology 2001; 21: 173-89.
15. Van Pampus MG, Dekker GA, Wolf H, et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999; 180: 1146-50.
16. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. New Engl J Med 1999; 340: 9-13.
17. Powers RW, Evans RW, Majors AK, et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998; 179: 1605-11.
18. Shehata HA, Nelson-Piercy C, Khamashata MA. Management of pregnancy in antiphospholipid syndrome. Rheum Dis Clin North Am 2001; 27: 643-59.
19. Dekker GA, de Vries JIP, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995; 173: 1042-8.
20. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Ann 1972; 1: 177-91.
21. Coss JC, Werb Z, Fisher SJ. Implantation and the placenta: Key pieces of the development puzzle. Science 1994; 266: 1508-18.
22. Khong TY, De Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 1981; 88: 876-81.
23. Damsky CH, Fitzgerald ML, Fisher SJ. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 1992; 89: 210-22.
24. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adherion phenotype. Once cause of defective endovacular nvasion in this syndrome? J Clin Invest 1997; 99: 2152-64.
25. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-58.
26. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenicfactors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-83.
27. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642-9.
28. Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003; 278: 12605-8.
29. Eremina V, Sood M, Haigh J. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 07-16.
30. Pridjian G. Placental Transfer, Fetomaternal interaction. Placental physiology and its role as go between. In: Avery G, Fletcher MA, Macdonald MG, Eds. Neonatology: Pathophysiology and Management of the Newborn, 5th ed, Philadelphia: J. B. Lippincott Co 1999; pp. 125-31.
31. Hytten FE, Paintin DB. Increase in plasma volume during normal pregnancy. J Obstet Gynaec Br Commonw 1973; 80: 884-7.
32. Scott DE. Anemia during pregnancy. Obstet Gynecol Annu 1972; 1: 219-44.
33. Clapp JF, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997; 80: 1469-73.
34. Robson SC, Hunter S, Boys RJ, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989; 256: H1060-5.
35. Lang R, Pridjian G, Feldman G, et al. Alterations in left ventricular mechanics in preeclampsia: Increased afterload or cardiomyopathy? Am Heart J 1991; 121: 1768-75.
36. Clark SL, Cotton DB, Pivarnik JM, et al. Position change and central hemodynamic profile during normal third-trimester pregnancy and post partum. Am J Obstet Gynecol 1991; 164: 883-7.
37. Longo LD. Maternal blood volume and cardiac output during preg nancy: A hypothesis of endocrinologic control. Am J Physiol 1983; 245: R720-9.
38. Mabie WC, DiSessa TG, Crocker LG, et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 1994; 170: 849-56.
39. Poppas A, Shroff SG, Korcarz CE, et al. Serial assessment of the cardiovascular system in normal pregnancy: Role of arterial compliance and pulsatile arterial load. Circulation 1997; 95: 2407-15.
40. Hibbard JU, Shroff SG, Lindheimer MD. Cardiovascular alterations in normal and preeclamptic pregnancy. In: Lindheimer MD, Roberts JM, Cunningham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy, 3rd ed. Academic Press 2009; pp. 249-67.
41. Chapman AB, Abraham WT, Zamudio S, et al. Temporal relation ships between hormonal and hemodynamic changes in early human pregnancy. Kidney International 1998; 54: 2056-63.
42. Brown MA, Zammit VC, Mitar DM. Extracellular fluid volumes in pregnancy-induced hypertension. J Hypertens 1992; 10: 61-6.
43. Lindheimer MD, Kanter D. Interpreting abnormal proteinuria in pregnancy. The need for a more pathophysiological approach. Obstet Gynecol 2010; 115: 365-75.
44. Sanchez-Ramos L, Adair CD, Kaunitz Am, et al. Calcium supplementation in mild preeclampsia remote from term: a randomized double-blind clinical trial. Obstet Gynecol 1995; 85: 915-18.
45. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med 1996; 335: 569-76.
46. Sibai BM, Kustermann L, Velasco J. Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, hemolysis, elevated liver enzymes, and low platelets syndrome, and postpartum acute renal failure: different clinical syndromes or just different names? Curr Opin Nephrol Hypertens 1994; 3: 436-45.
47. Egerman RS, Sibai BM. Imitators of preeclampsia and eclampsia. Clin Obstet Gynecol 1999; 42: 551-62.
48. Page EW, Christianson R. Influence of blood pressure changes with and without proteinuria upon outcome of pregnancy. Am J Obstet Gynecol 1976; 126: 821-33.
49. Sibai BM, Spinnato JA, Watson DL, et al. Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol 1984; 64: 319-25.
50. Luft FC, Gallery DM, Lindheimer MD. Normal and abnormal volume homeostasis. In: Lindheimer MD, Roberts JM, Cunninham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy, 3rd ed. Academic Press 2009; pp. 269-85.
51. Woods JB, Blake PG, Perry KG, et al. Ascites: a portent of cardiopulmonary complications in the preeclamptic patient with the syndrome of hemolysis, elevated liver enzymes, and low platelets. Obstet Gynecol 1992; 80: 87-91.
52. Landesman R, Douglas RG, Holze E. The bulbar conjunctival vascular bed in the toxemias of pregnancy. Am J Obstet Gynecol 1954; 68: 170-83.
53. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 1984; 7: 951-63.
54. Easterling, TR, Benedetti TJ, Schmucker BC, et al. Maternal hemodynamics in normal and preeclamptic pregnancies: A longitudinal study. Obstet Gynecol 1984; 150: 232-6.
55. Bosio P, McKenna PJ, O'Herlihy C, et al. Maternal central hemodynamics in hypertensive disorders of pregnancy-a longitudinal study. Am J Obstet Gynecol 1999; 94: 978-84.
56. Schwartz MM, Korbet SM. Primary focal segmental glomerulosclerosis: Pathology, histological variants, and pathogenesis. Am J Kidney Dis 1993; 22: 874-83.
57. Hayashi TT. The effect of Benemid on uric acid excretion in normal pregnancy and in preeclampsia. Am J Obstet Gynecol 1957; 73: 17-22.
58. Hayashi T. Uric acid and endogenous creatinine clearance studies in normal pregnancy and toxemias of pregnancy. Am J Obstet Gynecol 1956; 71: 859-70.
59. Port JD. Beauchamp NJ Jr. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics. 1998; 18: 353-67.
60. Cunningham FG, Fernandez CO, Hernandez C. Blindness associated with preeclampsia and eclampsia. Am J Obstet Gynecol 1995; 172: 1291-98.
61. Port JD. Beauchamp NJ. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 1998; 18: 353-67.
62. Sheehan HL, Lynch JB. Pathology of toxaemia of pregnancy. London, Churchill, Lingstone, 1973; pp. 524-53.
63. Govan ADT. The pathogenesis of eclamptic lesions. Pathol Microbiol 1961; 24: 561-75.
64. Redman WG, Bonnar J, Beilin L. Early platelet consumption in pre-eclampsia. Br Med J 1978; 1: 467-9.
65. Stubbs TM, Lazarchick J, Van Dorsten P, et al. Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am J Obstet Gynecol 1986; 155: 263-5.
66. Van Geet C, Spitz B, Vermylen J, et al. Urinary thromboxane metabolites in preeclampsia. Lancet 1990; 335i: 1168-9.
67. Wang Y, Walsh SW, Guo J, et al. Maternal levels of prostacyclin, thromboxane, vitamin E and ipid peroxides throughout normal pregnancy. Am J Obstet Gynecol 1991; 165: 1690-4.
68. Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombinantithrombin III complex and D-dimers. Gynecol Obstet Invest 1987; 24: 170-8.
69. Ferrazzani S, Caruso A, DeCarolis S, et al: Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol 1990; 162: 366-71.
70. Abu-Heija A. al-Chalabi H. el-Iloubani N. Abruptio placentae: risk factors and perinatal outcome. J Obstet Gynaecol Res 1998; 24: 141-4.
71. O'Shea TM. Dammann O. Antecedents of cerebral palsy in very low-birth weight infants. Clin Perinat 2000; 27: 285-302.
72. Sibai BM, McCubbin JH, Anderson GD, et al. Eclampsia I. Observations from 67 recent cases. Obstet Gynecol 1981; 58: 609-13.
73. Sibai BM, Mercer BM, Schiff E, et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818-22.
74. Odendaal HJ, Pattinson RC, Bam R, et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990; 76: 1070-5.
75. Bombrys AE, Barton JR, Nowacki EA, et al. Expectant management if severe preeclampsia at ess than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 2008; 199: 247.e1-6.
76. Bombrys AE, Barton JR, Habli M, Sibai BM. Expectant management of severe preeclampsia at 27 (0/7) to 33 (6/7) weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Perinat 2009; 26: 441-6.
77. Pridjian G, Puschett JB. Preeclampsia. Part 1: clinical and pathophysiologic considerations. Obstet GynSurv 2002;57(9):598-618.
78. Lucas MJ, Leveno KJ, Cunningham MD. A comparison of magne sium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201-5.
79. Ascarelli MH, Johnson V, May WL, et al. Individually determined postpartum magnesium sulfate therapy with clinical parameters to safely and cost-effectively shorten treatment for pre-eclampsia. Am J Obstet Gynecol 1998; 179: 952-6.
80. Nassar AH, Adra Am, Chakhtoura N, et al. Severe preeclampsia remote from term: labor nduction or elective cesarean delivery? Am J Obstet Gynecol 1998; 179: 1210-3.
81. Alanis MC, Robinson CJ, Hulsey TC, et al. Early-onset severe preeclampsia: induction of labor vs elective cesarean delivery and neonatal outcomes. Am J Obstet Gynecol 2008; 199: 262.e1-6.
82. Working Group Report on High Blood Pressure in Pregnancy. National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 00-3029, July 2000.
83. Wallace DH, Leveno KJ, Cunningham FG, et al. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet Gynecol 1995; 86: 193-9.
84. Richa F, Karim N, Yazbeck P. Obstetric admissions to the intensive care unit: an eight-year review. Lebanese Med J 2008; 56: 215-9.
85. Vasquez DN, Estenssoro E, Canales HS, et al. Clinical characteristics and outcomes of obstetric patients requiring ICU admission. Chest 2007; 131: 718-24.
86. Okafor UV, Aniebue U. Admission pattern and outcome in critical care obstetric patients. Int J Obstet Anesth 2004; 13: 164-6.
87. Loverro G, Pansini V, Greco P, Vimercati A, Parisi AM, Selvaggi L. Indications and outcome for ntensive care unit admissions during puerperium. Arch of Gynecol Obstet 2001; 265: 195-8.
88. Benedetti TJ, Kates R, Williams V. Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am J Obstet Gynecol 1985; 152: 330-4.
89. Sibai BM, Mabie BC, Harvey CJ, Gonzales, AR. Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. Am J Obstet Gynecol 1986; 156: 1174-9.
90. Young PF, Leighton NA, Jones PW, Anthony J, Johanson RB, Johanson R. Fluid management n severe preeclampsia (VESPA): survey of members of the International Society of Hypertension and Pregnancy (ISSHP). Hypertension in Pregnancy 2000; 3: 24959.
91. Lee W, Gonik B, Cotton DB. Urinary diagnostic indices in preeclampsia-associated oliguria: correlation with invasive hemo-dynamic monitoring. Am J Obstet Gynecol 1987; 156: 100-3.
92. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009; 113: 1299-306.
93. Newsome LR, Bramwell RS, Curling PE. Severe preeclampsia: hemodynamic effects of lumbar epidural anesthesia. Anesth Analg 1986; 65: 31-6.
94. Belfort MA, Rokey R, Saade GR, et al. Rapid echocardiographic assessment of left and right heart hemodynamics in critically ill obstetric patients. Am J Obstet Gynecol 1994; 171: 884-92.
95. Belfort MA, Mares A, Saade G, et al. Two-dimensional echocardiography and Doppler ultrasound in managing obstetric patients. Obstet Gynecol 1997; 90: 26-30.
96. Gilbert WM, Towner DR, Field N, Anthony J. The safety and utility of pulmonary artery catheterizationin servere preeclampsia and eclampsia. Am J Obstet Gynecol 2000; 182: 1397-403.
97. Clark SL, Cotton DB. Clinical indications for pulmonary artery catheterization in patients with severe preeclampsia. Am J Obstet Gynecol 1988; 158: 453-8.
98. Bolte AC, Dekker GA, van Eyck J, et al. Lack of agreement between central venous pressure and pulmonary artery wedge pressure in preeclampsia. Hypertension in Pregnancy 2000; 19: 162-71.
99. Cotton DB, Lee W, Huhta JC, Dorman KF. Hemodynamic profile of severe pregnancy induced hypertension. Am J Obstet Gynecol 1988; 158: 523-9.
100. Mabie WC, Ratts TE, Sibai TM. The central hemodynamics of severe preeclampsia. Am J Obstet Gynecol 1989; 161: 1443-8.
101. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol 1993: 100: 959-61.
102. Fenakel K, Fenakel G. Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991; 77: 331-7.
103. Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulfate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994; 101: 262-3.
104. Ansari MZ, Mueller BA, Krohn MA. Epidemiology of eclampsia. Europ J Epidemiology 1995; 11: 447-51.
105. Dahmus MA, Barton JR, Sibai BM. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol 1992; 167: 935-41.
106. Cunningham FG, Twickler D. Cerebral edema complicating eclampsia. Am J Obstet Gynecol 2000; 182: 94-100.
107. Munro PT. Management of eclampsia in the accident and emergency department. J Accid Emerg Med 2000; 17: 7-11.
108. Chames MC, Livingstone JC, Ivester TS, et al. Late postpartum elcmapsia: a preventable disease? Am J Obstet Gynecol 2002; 186: 1174-7.
109. Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009; 200: 481.e1-e7.
110. Mattar F, Sibai BM. Eclampsia: VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000; 182: 307-12.
111. Crosby ET. Obstetrical anaesthesia for patients with the syndrome of haemolysis, elevated liver enzymes and low platelets. Can J Anaesth 1991; 38: 227-33.
112. Sibai BM, Villar MA, Mabie BC. Acute renal failure in hypertensive disorders of pregnancy. Pregnancy outcome and remote prognosis in thirty-one consecutive cases. Am J Obstet Gynecol 1990; 162: 777-83.
113. Drakeley AJ, Le Roux PA, Anthony J, Penny J. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol 2002; 186: 253-6.
114. Muchnok C. Hogg JP. Granke DS. CT demonstration of resolution of hepatic lesions in HELLP syndrome: a case report. W V Med J. 1998; 94: 18-21.
115. Zissin R. Yaffe D. Fejgin M, et al. Hepatic infarction in preeclampsia as part of the HELLP syndrome: CT appearance. Abdom Imaging. 1999; 24: 594-6.
116. Strate T, Broering DC, Bloechle C, et al. Orthotopic liver transplantation for complicated HELLP syndrome. Case report and review of the literature. Arch Gynecol Obstet 2000; 264: 108-11.
117. rtin JN Jr. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105: 246-54.
118. Tang CH, Wu CS, Lee TH, et al. Preeclampsia-eclampsia and the risk of stroke among peripartum in Taiwan. Stroke 2009; 40: 1162-8.
119. Hinchey J, Chaves C, Appignani B, et al. A Reversible Posterior Leukoencephalopathy Syndrome. N Engl J Med 1996; 334: 494-500.
120. Stott VL, M. A. Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005; 35: 83-90.
121. Servillo G, Striano P, Striano S, et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med 2003; 29: 2323-6.
122. Johansson BB. The blood-brain barrier and cerebral blood flow in acute hypertension. Acta Med Scand Suppl 1983; 678: 107-12.
123. Zeeman GG, Cipola MJ, Cunningham FG. Cerebrobascular (Patho)Physiology in Preeclampsia/Eclampsia. In: Lindheimer MD, Roberts JM, Cunninham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy, 3rd ed. Academic Press 2009; pp. 227-47.
124. Donaldson JO. The brain in eclampsia. Hypertens Pregnancy 1994; 13: 115.